The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target

[1]  Kevin Wei,et al.  AXL is an essential factor and therapeutic target for metastatic ovarian cancer. , 2010, Cancer research.

[2]  R. Weimer,et al.  An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies , 2010, Oncogene.

[3]  Y. Hitoshi,et al.  R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. , 2010, Cancer research.

[4]  K. Pienta,et al.  GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche. , 2010, Neoplasia.

[5]  Bjørn Tore Gjertsen,et al.  Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival , 2009, Proceedings of the National Academy of Sciences.

[6]  J. Zha,et al.  Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis , 2009, Oncogene.

[7]  Nai-Wan Hsiao,et al.  The first pharmacophore model for potent NF-kappaB inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[8]  Johann S de Bono,et al.  Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer , 2009, Clinical Cancer Research.

[9]  G. Feldmann,et al.  The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target , 2009, Cancer biology & therapy.

[10]  P. Johnston,et al.  Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation. , 2008, Carcinogenesis.

[11]  László Orfi,et al.  AXL is a potential target for therapeutic intervention in breast cancer progression. , 2008, Cancer research.

[12]  A. Chinnaiyan,et al.  CXCL5 promotes prostate cancer progression. , 2008, Neoplasia.

[13]  G. Haas,et al.  The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. , 2008, The Canadian journal of urology.

[14]  A. Ullrich,et al.  Axl and Growth Arrest–Specific Gene 6 Are Frequently Overexpressed in Human Gliomas and Predict Poor Prognosis in Patients with Glioblastoma Multiforme , 2008, Clinical Cancer Research.

[15]  S. Chuang,et al.  Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL. , 2007, Cancer research.

[16]  H. Seno,et al.  Growth arrest‐specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway , 2007, Molecular carcinogenesis.

[17]  H. Otu,et al.  A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal anti-inflammatory drug-induced apoptosis and growth arrest of cancer cells. , 2006, Cancer research.

[18]  M. Essig,et al.  Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Y. Chu,et al.  Expression of axl in lung adenocarcinoma and correlation with tumor progression. , 2005, Neoplasia.

[20]  L. Castello,et al.  Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor , 2005, Journal of cellular physiology.

[21]  A. Koch.  Chemokines and their receptors in rheumatoid arthritis: future targets? , 2005, Arthritis and rheumatism.

[22]  B. Varnum,et al.  Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor. , 2005, Blood.

[23]  Marie Joseph,et al.  NF-κB-mediated repression of growth arrest- and DNA-damage-inducible proteins 45α and γ is essential for cancer cell survival , 2004 .

[24]  M. Blostein,et al.  Intracellular signaling pathways involved in Gas6-Axl-mediated survival of endothelial cells. , 2004, American journal of physiology. Heart and circulatory physiology.

[25]  D. Harrison,et al.  The JAK/STAT signaling pathway , 2004, Journal of Cell Science.

[26]  T. Libermann,et al.  Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. , 2003, Arthritis and rheumatism.

[27]  T. Libermann,et al.  Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. , 2003, Cancer research.

[28]  Y. Iwakura,et al.  IL-1 is required for tumor invasiveness and angiogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  H. Tomizawa,et al.  Discovery of quinazolines as a novel structural class of potent inhibitors of NF-κB activation , 2003 .

[30]  Wenhua Zheng,et al.  Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons. , 2002, Molecular pharmacology.

[31]  N. Munshi,et al.  Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications. , 2002, Blood.

[32]  M. Hung,et al.  Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis , 2002, Oncogene.

[33]  R. Verardo,et al.  Gas6 Anti-apoptotic Signaling Requires NF-κB Activation* , 2001, The Journal of Biological Chemistry.

[34]  B. Varnum,et al.  Gas 6 promotes Axl-mediated survival in pulmonary endothelial cells. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[35]  M. E. Ruaro,et al.  Gas6 Induces Growth, β-Catenin Stabilization, and T-Cell Factor Transcriptional Activation in Contact-Inhibited C57 Mammary Cells , 2001, Molecular and Cellular Biology.

[36]  D. Green,et al.  Regulation of FasL by NF-κB and AP-1 in Fas-dependent Thymineless Death of Human Colon Carcinoma Cells* , 2000, The Journal of Biological Chemistry.

[37]  J. Romashkova,et al.  NF-κB is a target of AKT in anti-apoptotic PDGF signalling , 1999, Nature.

[38]  T. Deerinck,et al.  The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.

[39]  A. Walz,et al.  Regulation and function of the CXC chemokine ENA‐78 in monocytes and its role in disease , 1997, Journal of leukocyte biology.

[40]  E. Ruaro,et al.  Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts , 1997, Molecular and cellular biology.

[41]  H. Yamane,et al.  Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6 , 1995, Nature.

[42]  C. Basilico,et al.  The receptor tyrosine kinase ARK mediates cell aggregation by homophilic binding , 1995, Molecular and cellular biology.

[43]  C. Schneider,et al.  The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade , 1993, Molecular and cellular biology.

[44]  A. Schulz,et al.  A novel putative tyrosine kinase receptor with oncogenic potential. , 1991, Oncogene.

[45]  R. Espinosa,et al.  axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase , 1991, Molecular and cellular biology.

[46]  Z. Li.  Growth arrest-specific genes and their research progress , 2009 .

[47]  M. A. M. Gakidis,et al.  Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK Complex , 2004, Cell Death and Differentiation.

[48]  Marie Joseph,et al.  NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survival. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[49]  H. Tomizawa,et al.  Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation. , 2003, Bioorganic & medicinal chemistry.

[50]  J. Jones,et al.  Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. , 2001, Nature.

[51]  A. Kraus,et al.  Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion. , 2001, European journal of cancer.

[52]  J. Romashkova,et al.  NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. , 1999, Nature.

[53]  R. Kandpal,et al.  A receptor tyrosine kinase, UFO/Axl, and other genes isolated by a modified differential display PCR are overexpressed in metastatic prostatic carcinoma cell line DU145. , 1999, Cancer detection and prevention.

[54]  R. Oyasu,et al.  Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. , 1997, Cancer research.